In brief
What should readers understand about Devices and Methods: External Fixation, Internal Nails, and Combined Approaches?
A neutral comparison of limb lengthening fixation methods — external fixation, internal lengthening nails, and combined strategies (LON, LATN) — covering how they differ operationally and what factors surgeons consider when choosing a method.
Limits: This page is educational context only and is not medical advice.
- Evidence
- Peer-reviewed evidence
- Source set
- Mixed source types
- Updated
- References
- 9 listed
Editorial responsibility: Limb Lengthening Library editorial team. Independent medical review is not claimed unless a named reviewer is listed. How sources are reviewed.
The Main Fixation Strategies
All methods use distraction osteogenesis, but they stabilize and move the bone differently. The practical comparison is not simply internal versus external: it includes device-specific load limits, pin-site exposure, number and timing of operations, implant fit, deformity-correction needs, follow-up, and regulatory status. [1]
External Fixation
Circular, monolateral, and hexapod frames connect to bone through pins or wires. They can provide powerful multiplanar correction and do not require a large intramedullary canal, but they create pin sites, visible external hardware, and frame-specific mobility and care demands. Pin-site problems are common; deep infection, alignment, joint stiffness, and regenerate problems remain possible.
Motorized Intramedullary Nails
Internal nails place a telescoping implant inside the bone and use a device-specific actuation system. They avoid external pin sites, but they still require osteotomy, locking screws, serial imaging, load restrictions, and usually a later removal operation. Nail diameter, length, curvature, stroke, entry approach, and magnetic-controller depth all need to match the patient and current instructions for use. [1][2]
Combined Methods: LON and LATN
Lengthening Over a Nail (LON)
In LON, an intramedullary nail and external fixator are present during distraction. The frame is removed and the nail is locked to support consolidation. In a randomized 31-limb study, LON shortened external-fixator time and had fewer overall reported complications than conventional Ilizarov lengthening, but 3 of 15 LON limbs developed deep intramedullary infection. Both findings belong in the consent discussion. [3]
Lengthening And Then Nailing (LATN)
LATN uses an external fixator for distraction and inserts an intramedullary nail at a later operation for consolidation. The approach reduces frame duration compared with classic external fixation in the original case-matched study, but adds a second major procedure. External and internal fixation are not intended to remain together through distraction, although conversion and infection precautions still require careful technique. [4]
Weight-Bearing Is Model- and Diameter-Specific
Do not apply one kilogram limit to every PRECICE nail. Permitted load depends on the exact product, diameter, bone, number of implanted devices, treatment phase, and current instructions. The treating surgeon may impose a stricter limit. A cleared or marketed design claim is not permission to exceed the written protocol. [2]
Current U.S. Regulatory Snapshot
The FDA states that stainless-steel Precice devices, including STRYDE, remain recalled and should not be implanted. The titanium PRECICE IMLL instructions include removal after one year. PRECICE MAX received 510(k) clearance in 2023. A separate Class II recall covers identified 2024 catalog and lot combinations; the open FDA record, updated July 14, 2026, tells customers to stop using and return affected unimplanted devices. It does not establish that every later or current PRECICE MAX unit is recalled or available. [2][5][6]
Availability Is Not Global or Static
Official U.S. records include clearances for FITBONE TAA and the FITBONE Transport and Lengthening System, but clearance does not prove local stocking, an indication for a particular patient, or the status of every catalog item. An open 2025 Class II recall identifies two units from specified FITBONE trochanteric nail lots; it is not a product-family recall. Verify the exact model, UDI or lot, current instructions, and local regulator record for every proposed implant. [7][8][9]
Questions That Make a Device Comparison Useful
- What is the exact manufacturer, model, diameter, stroke, and lot or catalog family?
- What load is permitted in each phase, and is that per limb or total body loading?
- What operations are planned for locking, frame removal, conversion, or nail removal?
- What is the current regulatory and recall status in the country where surgery occurs?
- What are this center's own device, infection, alignment, and reoperation outcomes?
Sources
Verification policy- Barakat AH et al. - Lengthening Nails for Distraction Osteogenesis: A Review of Current Practice and Presentation of Extended IndicationsAcademic journalAccessed 2026-07-12
- U.S. FDA - Update: NuVasive Specialized Orthopedics Precice Devices - Letter to Health Care ProvidersOfficial public sourceAccessed 2026-07-12
Current U.S. indications, weight and implant-count limits, one-year removal instruction, and stainless-steel device recall status.
- El-Husseini TF et al. - Comparison between lengthening over nail and conventional Ilizarov lengthening: a prospective randomized clinical studyAcademic journalAccessed 2026-07-12
- Rozbruch SR et al. - Limb lengthening and then insertion of an intramedullary nail: a case-matched comparisonAcademic journalAccessed 2026-07-12
- U.S. FDA - Class 2 Device Recall: Precice Max (Z-0500-2025)Official public sourceAccessed 2026-07-12
Recall initiated September 30, 2024. The FDA record was open when reviewed on July 12, 2026.
- U.S. FDA - 510(k) Premarket Notification K232267: Precice Max SystemOfficial public sourceAccessed 2026-07-15
- U.S. FDA - 510(k) Premarket Notification K203399: FITBONE TAAOfficial public sourceAccessed 2026-07-15
- U.S. FDA - 510(k) Premarket Notification K232169: FITBONE Transport and Lengthening SystemOfficial public sourceAccessed 2026-07-15
- U.S. FDA - Class 2 Device Recall: Fitbone Trochanteric Nail (Z-1977-2025)Official public sourceAccessed 2026-07-15
The open record identifies two units from specified lots and was last updated July 14, 2026.
Informational only. Not medical advice.